Chemotherapy-related vomiting
Conditions
Interventions
The control group:False acupoint sticking+western medicine standard antiemetic treatment
The experimental group:New acupoint sticking+western medicine standard antiemetic treatment
Sponsors
Beijing Hospital of TCM Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Definitely diagnosed as malignant tumor; 2. Patients who are being treated with intravenous chemotherapy drugs containing cisplatin or carboplatin yew or anthracycline with strong vomiting. 3. The patient has not received chemotherapy in the past or has been in the group for more than one month since the last chemotherapy; 4.ECOG/PS score =3 and expected survival time > 3 months; 5. Age 18-75 years old; 6. Agree to participate in this study and sign the informed consent form; Definitely diagnosed as malignant tumor.
Exclusion criteria
Exclusion criteria: 1. There are isolated brain/bone/adrenal metastases and radiotherapy is planned; 2. At the same time receiving other non-chemotherapy anti-tumor drugs =2; 3. Nausea and vomiting caused by tumor; 4 patients with serious diseases of heart liver kidney hematopoietic system and endocrine system; 5. Pregnant or lactating women or serious heart lung liver kidney blood system etc. are considered unsuitable for this study by the researchers after evaluation; 6. Known allergic to test articles and drugs; 7. The subject is participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence rate above CINV-II level; | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of treatment failure time;FLIE;PFS-R;VAS;EQ-5D; | — |
Countries
China
Contacts
Public ContactGuowang Yang
Beijing Hospital of TCM Capital Medical University
Outcome results
None listed